LeonaBio, Inc. (LONA) Current Ratio
- Current ratio · latest quarter: Value 7.01×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 7.01× | Current assets / current liabilities. $54.81M ÷ $7.82M ≈ 7.01× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 54.81M USD | Assets, Current |
| Current obligations | 7.82M USD | Liabilities, Current |
| Cash and equivalents | 32.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 2.42M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $54.81M | $7.82M | $32.32M | (m) | (m) | (m) | $2.42M | (m) | 7.01× |
| 2026-03-31 | $69.20M | $6.67M | $32.83M | (m) | (m) | (m) | $1.76M | (m) | 10.38× |
| 2025-12-31 | $89.46M | $47.50M | $69.28M | (m) | (m) | (m) | $4.59M | (m) | 1.88× |
| 2025-09-30 | $27.02M | $2.79M | $20.87M | (m) | (m) | (m) | $266.00K | (m) | 9.70× |
| 2025-06-30 | $32.22M | $2.98M | $19.89M | (m) | (m) | (m) | $171.00K | (m) | 10.81× |
| 2025-03-31 | $39.85M | $5.49M | $26.42M | (m) | (m) | (m) | $867.00K | (m) | 7.26× |
| 2024-12-31 | $54.84M | $13.13M | $48.44M | (m) | (m) | (m) | $319.00K | (m) | 4.18× |
| 2024-09-30 | $82.00M | $27.75M | $68.86M | (m) | (m) | (m) | $388.00K | (m) | 2.95× |
| 2024-06-30 | $106.70M | $26.90M | $73.83M | (m) | (m) | (m) | $475.00K | (m) | 3.97× |
| 2024-03-31 | $128.64M | $25.60M | $77.82M | (m) | (m) | (m) | $681.00K | (m) | 5.03× |
| 2023-12-31 | $154.73M | $28.84M | $90.58M | (m) | (m) | (m) | $129.00K | (m) | 5.37× |
| 2023-09-30 | $178.50M | $28.62M | $110.33M | (m) | (m) | (m) | $1.71M | (m) | 6.24× |
| 2023-06-30 | $192.13M | $21.66M | $113.63M | (m) | (m) | (m) | $612.00K | (m) | 8.87× |
| 2023-03-31 | $192.90M | $20.15M | $105.18M | (m) | (m) | (m) | $892.00K | (m) | 9.57× |
| 2022-12-31 | $207.53M | $21.43M | $95.97M | (m) | (m) | (m) | $2.50M | (m) | 9.68× |
| 2022-09-30 | $228.97M | $10.26M | $87.05M | (m) | (m) | (m) | $751.00K | (m) | 22.31× |
| 2022-06-30 | $255.86M | $9.69M | $95.06M | (m) | (m) | (m) | $605.00K | (m) | 26.40× |
| 2022-03-31 | $269.15M | $9.47M | $117.81M | (m) | (m) | (m) | $1.43M | (m) | 28.42× |
| 2021-12-31 | $260.80M | $9.29M | $110.54M | (m) | (m) | (m) | $567.00K | (m) | 28.07× |
| 2021-09-30 | $238.99M | $9.39M | $107.33M | (m) | (m) | (m) | $959.00K | (m) | 25.46× |
| 2021-06-30 | $290.50M | $7.63M | $131.70M | (m) | (m) | (m) | $1.17M | (m) | 38.05× |
| 2021-03-31 | $311.57M | $4.50M | $127.82M | (m) | (m) | (m) | $1.69M | (m) | 69.28× |
| 2020-12-31 | $192.34M | $4.41M | $60.63M | (m) | (m) | (m) | $1.16M | (m) | 43.66× |
| 2020-09-30 | $232.27M | $7.55M | $165.72M | (m) | (m) | (m) | $3.87M | (m) | 30.75× |
| 2019-12-31 | $2.16M | $1.27M | $2.06M | (m) | (m) | (m) | $421.00K | (m) | 1.70× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |